[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:nutm1-wt-allele":3},{"name":4,"total":5,"recruiting":5,"trials":6},"NUTM1 wt Allele",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07050186","Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma",[11],"Phase 2","RECRUITING","2026-08-26T02:15:39.267524Z","2026-05-05T02:43:28.124822Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05019716","Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma",[19],"Phase 1\u002FPhase 2","2026-08-26T02:18:51.833592Z","2026-04-29T02:57:57.082361Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT05372640","Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors",[26],"Phase 1","2026-08-26T02:16:59.895916Z","2026-05-05T02:43:28.342858Z"]